Scientists dig deep into Mepolizumab's effects on nasal polyps and asthma
NCT ID NCT06069310
First seen Apr 19, 2026 · Last updated May 20, 2026 · Updated 5 times
Summary
This observational study follows 40 adults with chronic sinusitis with nasal polyps, with or without severe asthma, who are starting mepolizumab. Researchers collect nasal, blood, and sputum samples before treatment and at 3, 6, and 12 months to track changes in symptoms, gene activity, and airway bacteria. The goal is to find biological markers that predict who responds best to the drug, potentially reducing the need for steroids.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pulmonary Dept First ICU Evangelismos Hospital
Athens, 10676, Greece
-
Pulmonary Dept First ICU, Evagelismos Hospital
Athens, Attica, 10676, Greece
Conditions
Explore the condition pages connected to this study.